About Nalpropion Pharmaceuticals
Nalpropion Pharmaceuticals is a Healthcare company based in San Diego (United States) founded in 2018, and was acquired by Currax in September 2019. Branded and generic pharmaceutical products are distributed across therapeutic areas. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas. Its legal entity is Currax Pharmaceuticals LLC.
Company details
Nalpropion Pharmaceuticals was founded in 2018 and is based in San Diego, United States. Operations focus on the distribution of a portfolio of branded and generic medications targeting various therapeutic areas within the pharmaceutical sector. Clinical trials are conducted, and support is provided for independent research along with educational grants. A compliance program is maintained, and adherence to a code of business conduct and ethics is ensured.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nalpropion.com
- Social LinkedIn
- Acquired by Currax (Sep 2019)
- Legal Name Currax Pharmaceuticals Llc
Investors in Nalpropion Pharmaceuticals
Nalpropion Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Currax.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Currax Pharmaceuticals is engaged in distributing life-changing medications worldwide. | curraxpharma.com | Brentwood, United States |
Investor details for Nalpropion Pharmaceuticals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Nalpropion Pharmaceuticals
2 dated milestones of Nalpropion Pharmaceuticals across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Nalpropion Pharmaceuticals is founded.
- Exit Acquired by Currax.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Nalpropion Pharmaceuticals (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nalpropion Pharmaceuticals
Nalpropion Pharmaceuticals was founded in 2018.
Nalpropion Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Nalpropion Pharmaceuticals was founded in 2018 and is based in San Diego, United States. Operations focus on the distribution of a portfolio of branded and generic medications targeting various therapeutic areas within the pharmaceutical sector. Clinical trials are conducted, and support is provided for independent research along with educational grants. A compliance program is maintained, and adherence to a code of business conduct and ethics is ensured.
Nalpropion Pharmaceuticals has 1 investor. Key investors include Currax.
Nalpropion Pharmaceuticals operates through Currax Pharmaceuticals Llc.
Yes. Nalpropion Pharmaceuticals was acquired by Currax in September 2019.